文献速递MDS 与骨髓增殖性肿瘤贫血与红细胞疾病

SAMD9/SAMD9L胚系突变损害原代造血细胞的多条通路

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
PubMed 文献 · Leukemia · 2021-03-17

儿童MDS常伴7号染色体缺失及SAMD9/SAMD9L胚系突变。本研究用慢病毒过表达在原代小鼠或人造血干祖细胞中评估野生型及突变型SAMD9/SAMD9L的功能影响,发现二者是多功能蛋白,改变细胞周期、增殖和蛋白翻译,并促DNA损伤修复缺陷和凋亡。

要点

  • SAMD9/SAMD9L突变可损害造血干祖细胞多通路功能
  • 突变导致DNA损伤修复缺陷并最终促凋亡
  • 这或可解释儿童MDS骨髓低细胞性的发生机制

核心结论

  • SAMD9和SAMD9L为多功能蛋白,其突变可改变造血干祖细胞的细胞周期、增殖与蛋白翻译,并促DNA损伤修复缺陷和凋亡。

研究设计与样本

  • 采用慢病毒过表达方法,在原代小鼠或人造血干祖细胞中评估野生型与突变型SAMD9或SAMD9L的功能影响。
  • 结合蛋白质相互作用组分析、转录谱分析和功能验证开展研究。

主要发现

  • SAMD9和SAMD9L引起造血干祖细胞细胞周期、细胞增殖和蛋白翻译的深刻改变。
  • 这些基因及其突变的表达形成促DNA损伤修复缺陷的细胞环境,并最终导致造血细胞凋亡。

临床怎么用

  • 对儿童MDS伴7号染色体缺失或骨髓低细胞性者,可关注SAMD9/SAMD9L胚系突变及其对造血干祖细胞的多通路影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pediatric myelodysplastic syndromes (MDS) are a heterogeneous disease group associated with impaired hematopoiesis, bone marrow hypocellularity, and frequently have deletions involving chromosome 7 (monosomy 7). We and others recently identified heterozygous germline mutations in SAMD9 and SAMD9L in children with monosomy 7 and MDS. We previously demonstrated an antiproliferative effect of these gene products in non-hematopoietic cells, which was exacerbated by their patient-associated mutations. Here, we used a lentiviral overexpression approach to assess the functional impact and underlying cellular processes of wild-type and mutant SAMD9 or SAMD9L in primary mouse or human hematopoietic stem and progenitor cells (HSPC). Using a combination of protein interactome analyses, transcriptional profiling, and functional validation, we show that SAMD9 and SAMD9L are multifunctional proteins that cause profound alterations in cell cycle, cell proliferation, and protein translation in HSPCs. Importantly, our molecular and functional studies also demonstrated that expression of these genes and their mutations leads to a cellular environment that promotes DNA damage repair defects and ultimately apoptosis in hematopoietic cells. This study provides novel functional insights into SAMD9 and SAMD9L and how their mutations can potentially alter hematopoietic function and lead to bone marrow hypocellularity, a hallmark of pediatric MDS.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Thomas ME, Abdelhamed S, Hiltenbrand R, et al. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells. Leukemia. 2021. PMID: 33731850. doi:10.1038/s41375-021-01212-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。